Captrust Financial Advisors Acquires 1,043 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Captrust Financial Advisors raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 54.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,969 shares of the medical instruments supplier’s stock after buying an additional 1,043 shares during the quarter. Captrust Financial Advisors’ holdings in ICU Medical were worth $541,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allworth Financial LP grew its holdings in shares of ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Xponance Inc. grew its holdings in shares of ICU Medical by 6.0% in the 2nd quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock worth $235,000 after purchasing an additional 112 shares during the last quarter. Equitable Trust Co. grew its holdings in shares of ICU Medical by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock worth $950,000 after purchasing an additional 112 shares during the last quarter. CWM LLC grew its holdings in shares of ICU Medical by 18.5% in the 2nd quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 120 shares during the last quarter. Finally, Hexagon Capital Partners LLC lifted its position in ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 122 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Raymond James upped their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. KeyCorp upped their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research report on Wednesday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, ICU Medical has a consensus rating of “Moderate Buy” and an average target price of $177.25.

ICU Medical Stock Performance

ICU Medical stock opened at $166.19 on Thursday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The company has a market cap of $4.07 billion, a PE ratio of -36.37 and a beta of 0.62. The company’s 50-day moving average is $171.70 and its two-hundred day moving average is $150.45.

Insider Buying and Selling at ICU Medical

In related news, Director David C. Greenberg sold 972 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now directly owns 5,037 shares in the company, valued at $796,400.07. This trade represents a 16.18 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $18,665,666.78. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,364 shares of company stock worth $6,869,878. Company insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.